China Health Sets 30 June Board Meeting to Approve FY2025/26 Results
Bulletin Express
Jun 17
China Health Group Limited has scheduled a board meeting for 30 June 2026 to review and approve the consolidated final results for the financial year ended 31 March 2026. The agenda also covers other routine board matters.
The notice, dated 17 June 2026 and signed by Chairman and Executive Director Cao Xu, confirms the current board structure: three executive directors (Cao Xu, Chung Ho, Ying Rensi), two non-executive directors (Ying Wei, Huang Lianhai) and three independent non-executive directors (Li Hongyi, Wu Hui, Yang Huimin).
Release of the audited annual results is expected shortly after the meeting, aligning with customary disclosure timelines for Hong Kong-listed companies.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.